Prudent Man Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $772K | Buy |
1,735
+376
| +28% | +$167K | 0.25% | 93 |
|
|
2025
Q1 | $659K | Sell |
1,359
-403
| -23% | -$195K | 0.24% | 100 |
|
|
2024
Q4 | $710K | Sell |
1,762
-122
| -6% | -$49.1K | 0.26% | 84 |
|
|
2024
Q3 | $876K | Sell |
1,884
-124
| -6% | -$57.7K | 0.29% | 85 |
|
|
2024
Q2 | $941K | Buy |
2,008
+74
| +4% | +$34.7K | 0.33% | 69 |
|
|
2024
Q1 | $808K | Sell |
1,934
-123
| -6% | -$51.4K | 0.3% | 79 |
|
|
2023
Q4 | $837K | Sell |
2,057
-30
| -1% | -$12.2K | 0.31% | 71 |
|
|
2023
Q3 | $726K | Sell |
2,087
-71
| -3% | -$24.7K | 0.29% | 79 |
|
|
2023
Q2 | $759K | Sell |
2,158
-30
| -1% | -$10.6K | 0.29% | 74 |
|
|
2023
Q1 | $689K | Sell |
2,188
-25
| -1% | -$7.87K | 0.27% | 84 |
|
|
2022
Q4 | $639K | Buy |
2,213
+588
| +36% | +$170K | 0.26% | 98 |
|
|
2022
Q3 | $471K | Sell |
1,625
-12
| -0.7% | -$3.48K | 0.22% | 95 |
|
|
2022
Q2 | $461K | Sell |
1,637
-28
| -2% | -$7.89K | 0.22% | 95 |
|
|
2022
Q1 | $435K | Sell |
1,665
-59
| -3% | -$15.4K | 0.18% | 105 |
|
|
2021
Q4 | $379K | Sell |
1,724
-3
| -0.2% | -$660 | 0.14% | 114 |
|
|
2021
Q3 | $313K | Sell |
1,727
-21
| -1% | -$3.81K | 0.12% | 136 |
|
|
2021
Q2 | $352K | Buy |
1,748
+53
| +3% | +$10.7K | 0.14% | 122 |
|
|
2021
Q1 | $364K | Buy |
1,695
+83
| +5% | +$17.8K | 0.15% | 116 |
|
|
2020
Q4 | $381K | Sell |
1,612
-31
| -2% | -$7.33K | 0.16% | 110 |
|
|
2020
Q3 | $447K | Buy |
1,643
+54
| +3% | +$14.7K | 0.24% | 87 |
|
|
2020
Q2 | $461K | Buy |
+1,589
| New | +$461K | 0.41% | 70 |
|